Cargando…

Interleukin 6 and depression in patients affected by Covid-19()

INTRODUCTION: Rise of central cytokines resulting from infections produces neuronal changes. Covid-19 allows the study of depressive symptoms in sustained stress and its relationship with molecular mechanisms. OBJECTIVES: To assess correlation between IL-6, IL-1β and TNF-α and depressive symptoms. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Serrano García, Antonio, Montánchez Mateo, Judith, Franch Pato, Clara Margarita, Gómez Martínez, Rocío, García Vázquez, Paula, González Rodríguez, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931695/
https://www.ncbi.nlm.nih.gov/pubmed/33688583
http://dx.doi.org/10.1016/j.medcle.2020.11.013
_version_ 1783660345304285184
author Serrano García, Antonio
Montánchez Mateo, Judith
Franch Pato, Clara Margarita
Gómez Martínez, Rocío
García Vázquez, Paula
González Rodríguez, Isabel
author_facet Serrano García, Antonio
Montánchez Mateo, Judith
Franch Pato, Clara Margarita
Gómez Martínez, Rocío
García Vázquez, Paula
González Rodríguez, Isabel
author_sort Serrano García, Antonio
collection PubMed
description INTRODUCTION: Rise of central cytokines resulting from infections produces neuronal changes. Covid-19 allows the study of depressive symptoms in sustained stress and its relationship with molecular mechanisms. OBJECTIVES: To assess correlation between IL-6, IL-1β and TNF-α and depressive symptoms. Characterize the depressive symptoms present. METHODS: Observational study. Patients admitted for Covid-19 older than 60 years with a interleukin determination were included. The Yesavage Geriatric Depression Scale was used, associating each item with a neurotransmitter. RESULTS: 27 patients included. We did not find correlation between IL-6 levels and the GDS scale score (rho = 0.204; 95% CI −0.192 to 0.543); with IL-1β levels (rho = −0.126; 95% CI −0.490 to 0.276); nor of TNF-α (rho = −0.033; 95% CI −0.416 to 0.360). 3 patients (11.1%) presented score compatible with depressive disorder. It was associated with a deficiency of Noradrenaline and Serotonin. CONCLUSIONS: We found no correlation between the levels of IL-6, IL-1β, and TNF-α with the GDS score. Depressive symptomatology is similar to vascular depressions.
format Online
Article
Text
id pubmed-7931695
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-79316952021-03-05 Interleukin 6 and depression in patients affected by Covid-19() Serrano García, Antonio Montánchez Mateo, Judith Franch Pato, Clara Margarita Gómez Martínez, Rocío García Vázquez, Paula González Rodríguez, Isabel Med Clin (Engl Ed) Brief Report INTRODUCTION: Rise of central cytokines resulting from infections produces neuronal changes. Covid-19 allows the study of depressive symptoms in sustained stress and its relationship with molecular mechanisms. OBJECTIVES: To assess correlation between IL-6, IL-1β and TNF-α and depressive symptoms. Characterize the depressive symptoms present. METHODS: Observational study. Patients admitted for Covid-19 older than 60 years with a interleukin determination were included. The Yesavage Geriatric Depression Scale was used, associating each item with a neurotransmitter. RESULTS: 27 patients included. We did not find correlation between IL-6 levels and the GDS scale score (rho = 0.204; 95% CI −0.192 to 0.543); with IL-1β levels (rho = −0.126; 95% CI −0.490 to 0.276); nor of TNF-α (rho = −0.033; 95% CI −0.416 to 0.360). 3 patients (11.1%) presented score compatible with depressive disorder. It was associated with a deficiency of Noradrenaline and Serotonin. CONCLUSIONS: We found no correlation between the levels of IL-6, IL-1β, and TNF-α with the GDS score. Depressive symptomatology is similar to vascular depressions. Elsevier España, S.L.U. 2021-04-09 2021-03-04 /pmc/articles/PMC7931695/ /pubmed/33688583 http://dx.doi.org/10.1016/j.medcle.2020.11.013 Text en © 2020 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Brief Report
Serrano García, Antonio
Montánchez Mateo, Judith
Franch Pato, Clara Margarita
Gómez Martínez, Rocío
García Vázquez, Paula
González Rodríguez, Isabel
Interleukin 6 and depression in patients affected by Covid-19()
title Interleukin 6 and depression in patients affected by Covid-19()
title_full Interleukin 6 and depression in patients affected by Covid-19()
title_fullStr Interleukin 6 and depression in patients affected by Covid-19()
title_full_unstemmed Interleukin 6 and depression in patients affected by Covid-19()
title_short Interleukin 6 and depression in patients affected by Covid-19()
title_sort interleukin 6 and depression in patients affected by covid-19()
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931695/
https://www.ncbi.nlm.nih.gov/pubmed/33688583
http://dx.doi.org/10.1016/j.medcle.2020.11.013
work_keys_str_mv AT serranogarciaantonio interleukin6anddepressioninpatientsaffectedbycovid19
AT montanchezmateojudith interleukin6anddepressioninpatientsaffectedbycovid19
AT franchpatoclaramargarita interleukin6anddepressioninpatientsaffectedbycovid19
AT gomezmartinezrocio interleukin6anddepressioninpatientsaffectedbycovid19
AT garciavazquezpaula interleukin6anddepressioninpatientsaffectedbycovid19
AT gonzalezrodriguezisabel interleukin6anddepressioninpatientsaffectedbycovid19